One of the challenges in cell biology is that many mechanistic models are built from observations made in one, or only a few, cellular systems. These models then become part of our textbook understanding of molecular biology.
We are often surprised when cells do not behave as expected when we perturb a biochemical pathway. But perhaps the problem is not that cells are behaving unexpectedly; it is that our models are too general.
A major source of this discrepancy is the heterogeneity of molecular mechanisms across cells: mechanisms can differ between lineages and even between subtypes of cells within the same lineage. A good example is cell signalling. Our canonical understanding of signalling pathways often provides only a limited explanation for why some tumours respond to targeted therapies while others do not.
Our lab is particularly interested in understanding this heterogeneity of molecular processes across mammalian cells, and in identifying the molecular mechanisms that underpin it. Two recent studies from our group illustrate this approach:
👉 In a study recently published in EMBO Reports, Sandra M. Martin, Ph.D, in collaboration with Helfrid Hochegger and his group, found that the mechanisms used by myeloid cells to regulate cell biology can differ substantially from those operating in cells derived from solid tumours.
👉 In a separate study, recently published in npj Precision Oncology, Luke Higgins took a systematic approach to characterising and modelling proteomic heterogeneity across tumour types.
Mapping the molecular differences and biomarkers that distinguish cell types is an important first step. The next challenge is to understand the fundamental molecular basis of this heterogeneity.
Doing so could change how we think about cell biology, and, importantly, provide a more rational framework for predicting how individual cells or tumours will respond when a particular molecular pathway is perturbed. Rather than asking why cells don’t behave according to our models, perhaps we should ask whether our models adequately capture the diversity of cells in the first place.